Sandoz Matches Teva On US Rifaximin Launch Date

Company Had Been Sued In October Last Year

 
• By Dean Rudge
  
Handshake
Sandoz is eyeing market entry almost two years ahead of patent expiry • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Generics Bulletin